Belongs to

• Center for Hematologic Malignancies

Types of Work

["2019"]

[[["Meeting Abstracts",288],["Journal Articles",286],["Reviews",16],["Book Sections",9],["Research Letters",7],["Correspondences",2],["Guidelines",2],["Conference Papers",1],["Editorials",1]]]

[612]

Popular keywords

• adult
• aged
• article
• controlled study
• female
• human
• major clinical study
• male
• multiple myeloma
• priority journal

Recent Works

1. CARTITUDE-1: Phase 1b/2 study of ciltacabtagene autoleucel in relapsed/refractory multiple myeloma

   Meeting Abstract

   Madduri, D.; Berdeja, J.; Usmani, S.; Jakubowiak, A.; Agha, M.; Cohen, A.; Stewart, A. K.; Hari, P.; Htut, M.; O'Donnell, E.; more...
   British Journal of Haematology (2021)

   Fulltext@MSK | Save
2. Phase I study of the CD47 blocker TTI-621 in patients with relapsed or refractory hematologic malignancies

   Journal Article

   Ansell, S. M.; Maris, M. B.; Lesokhin, A. M.; Chen, R. W.; Flinn, I. W.; Sawas, A.; Minden, M. D.; Villa, D.; Percival, M. E. M.; Advani, A. S.; more...
   Clinical Cancer Research (2021)

   Fulltext@MSK | Save
3. Cellular therapy during COVID-19: Lessons learned and preparing for subsequent waves

   Journal Article

   Nawas, M. T.; Shah, G. L.; Feldman, D. R.; Ruiz, J. D.; Robilotti, E. V.; Aslam, A. A.; Dundas, M.; Kamboj, M.; Barker, J. N.; Cho, C.; more...
   Transplantation and Cellular Therapy (2021)

   Fulltext@MSK | Save